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The aims of this study were to identify the morphological
diversities and anatomical variations of pancreatic ductal
system and to define the relationships between pancreatic duc-
tal systems, pancreaticobiliary diseases, and procedure- related
complications, including post-ERCP pancreatitis. This study
included 582 patients in whom both pancreatic duct (PD) and
common bile duct were clearly visible by ERCP. PD systems
were categorized into four types according to the relationship
between common bile duct and PD. In types A and B, Wirsung
duct formed the main PD. In type C, Wirsung duct did not
form the main PD. If PD system did not fall into any of these
three types, it was categorized as type D. The distribution of
types among pancreatic ducts examined was as follows: type
A: 491 cases (84.4%), type B: 56 cases (9.6%), type C: 20
cases (3.4%), and type D: 15 cases (2.6%). The anomalous
anatomic variations of PD systems were divided into migra-
tion, fusion, and duplication anomalies. PD anomalies were
noted in 51 patients, of which 19 (3.3%) were fusion anom-
alies (12 complete pancreas divisum, 7 incomplete pancreas
divisum), and 32 (5.5%) were duplication anomalies (5 number
variations, 27 form variations). No significant relationships
between various PD morphologies and pancreaticobiliary
diseases were found. However, post- ERCP hyperamylasemia
was more frequently found in types C (41.7%), D (50%) and
A (19.8%) than in type B (9.4%). In summary, whether
Wirsung duct forms the main PD and the presence or absence
of the opening of the Santorini duct are both important factors
in determining the development of pancreatitis and hypera-
mylasemia after ERCP.
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INTRODUCTION
Endoscopic retrograde cholangiopancreatico-
graphy (ERCP) allows for visualization of pan-
creatic duct (PD) and bile duct. It is the confirma-
tive tool for diagnosis and treatment of disorders
of PD and bile duct, even though magnetic reso-
nance cholangiopancreaticography has emerged
as an alternative procedure.
1-5 In addition, the
images of PD and bile duct obtained by ERCP
have been shown to agree with the pattern and
anomaly of PD detected by surgery or autopsy.
6,7
Due to the close relationship between pan-
creatic ductal system and bile duct in develop-
ment and anatomy, abnormalities in one often
affect the other. For example, the anomalous pan-
creaticobiliary ductal union is one of the impor-
tant risk factors for gallbladder and bile duct
cancer.
8,9 However, the relationship between the
morphology of PD and pancreaticobiliary dis-
eases has not been clearly elucidated. Hence,
based upon the images of pancreatic ductal
system and bile duct obtained by ERCP, patterns
of PD and anatomical variations were classified,
and associations between the patterns and
anomalies with pancreaticobiliary diseases and
post-ERCP complications were assessed.
MATERIALS AND METHODS
Patients
Among patients who underwent ERCP at
Severance Hospital, Yonsei University College of
Medicine from January 1992 to November 1996,
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582 patients whose bile duct and PD were com-
pletely visualized were included in this study. The
patients' medical records and radiologic images,
including the ERCP image, were retrospectively
reviewed. ERCP was performed according to stan-
dard procedures, with the patient under sedation
with intramuscular meperidine (up to 1 mg/kg,
but no more than 50 mg) and midazolam.
Morphologies of pancreatic ducts
Based on the relationship of pancreatic Wirsung
and Santorini ducts and common bile duct to each
other and to duodenum, the ductal systems were
divided into four groups as follows (Fig. 1): In
type A and B, Wirsung duct is the main PD and
it drains into the major papilla of duodenum. In
type A, Santorini duct is an accessory PD which
is obliterated or absent (if the accessory PD is
absent, the main PD should be straight rather than
curved like a chain or wheel). Santorini duct of
type B is an accessory PD and runs into the minor
papilla of duodenum. The type C is a PD system
in which Santorini duct forms the main PD and
drains into the minor papilla of duodenum.
Wirsung duct of type C forms an accessory PD
which is obliterated or drains into the major pa-
pilla of duodenum. The PD systems other than
type A, B, and C are were defined as type D. In
addition, according to the morphology of the
main PD and the accessory PD, type A was di-
vided into 6 subtypes, type B into 5 subtypes, and
types C and D were divided into 4 subtypes each
(Fig. 1).
10
Anatomical anomalies of pancreatic ducts
Anatomical anomalies of PD were classified as
either a migration anomaly (annular pancreas,
ectopic pancreas), a fusion anomaly (complete, in-
complete pancreas divisum), or a duplication ano-
maly (number variation, form variation) accord-
ing to developmental aspects of PD system.
11
Definitions
The definition of pancreatitis and the grading of
its severity were based on consensus criteria.
12
Post-ERCP pancreatitis was diagnosed when
new-onset or increased abdominal pain lasted for
more than 24 hours, caused the unplanned admis-
sion of an outpatient for more than one night, or
prolonged the planned admission of an inpatient,
and was associated with a serum amylase level
increase of at least three times above normal, at
approximately 18 hours (the next morning) after
the procedure. Post-ERCP hyperamylasemia was
defined as a normal clinical condition at 24 h after
the procedure but with serum amylase levels
elevated above the normal upper limit (115 U/L).
The operators rated selective cannulation as
“difficult” when three or more attempts were
required, due to difficulty in reaching the proper
placement angle for selective cannulation, unusual
anatomy, and/or accidental submucosal contrast
media injection. If bile duct cannulation was dif-
ficult, a needle knife or precut papillotomy was
performed, and/or a guide wire through the
second sphincterotome or standard catheter chan-
nel was used, or the procedure was abandoned
and repeated at a later session.
Statistics
The difference in clinicopathological parameters
between types, including post-ERCP complica-
tions and specific pancreaticobiliary diseases,
were analyzed with the Chi-square test.
Fig. 1. Classification of Pancreatic Ductal System. In types
A and B, Wirsung duct formed the main PD, however, in
type C, Wirsung duct did not form the main PD. In type
A, Santorini duct is either obliterated or absent. Santorini
duct of type B is an accessory PD and runs into the minor
papilla of duodenum. If PD system did not fall into any
of these 3 groups, it was classified as type D.Morphologies of the Pancreatic Ductal System
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RESULTS
Clinical characteristics of the study population
The mean age of the study population (n = 582)
was 52.8 years. Three hundred twenty-five of the
patients were male. The indications for ERCP in-
cluded choledocholithiasis, jaundice, chronic pan-
creatitis, pancreatic tumor, abdominal pain, and
bile duct dilatation. The final diagnosis, confirmed
with ERCP, was gallstone in 253 cases (40.4%),
chronic pancreatitis in 77 cases (13.2%), cholangio-
carcinoma in 48 cases (8.2%), pancreatic cancer in
39 cases (6.7%), and acute pancreatitis in 21 cases
(3.6%).
Frequency of pancreatic duct types
The frequency of PD types found was as
follows: type A: 491 cases (84.4%), type B: 56 cases
(9.6%), type C: 20 cases (3.4%), and type D: 15
cases (2.6%). The type B system, in which Santorini
duct is present and drains into the minor papilla
of duodenum, was found more frequently in men
(11.7% in men vs. 1.5% in women). There were no
other significant differences between genders. The
main types were further subdivided according to
the morphologic relationship between the main
and accessory ducts. The number of cases seen for
each type was as follows: subtype A1: 254 cases
(43.6%), subtype A2: 70 cases (12%), subtype A3: 15
cases (2.6%), subtype A4: 2 cases (0.3%), subtype
A5: 26 cases (4.5%), and subtype A6: 124 cases
(21.3%); subtype B1: 37 cases (6.4%), B2: 6 cases
(1.0%), B3: 10 cases (1.7%), B4: 2 cases (0.3%) and
B5: 1 case (0.2%); subtype C1: 12 cases (2.1%), C2:
7 cases (1.2%), C4: 1 case (0.2%), and C3 subtype
was not detected; subtype D1: 12 cases (2.0%), and
D2, D3, and D4 had 1 case (0.2%) each (Table 1).
Anatomical anomalies of the pancreatic duct
An anatomical anomaly of the pancreatic duct
was observed in a total of 51 cases (8.8%). A
fusion anomaly was found in 19 cases (3.3%), and
a duplication anomaly was found in 32 cases (5.5
%). In the fusion anomaly cases, a complete pan-
creatic divisum was seen in 12 cases (2.1%) and
an incomplete pancreatic divisum was seen in 7
cases (1.2%). In the duplication anomaly cases,
number variation was seen in 5 cases (0.9%) and
form variation in 27 cases (4.6%) with ring-type in
18 cases (3.1%), and spiral-type in 9 cases (1.5%)
(Table 2).
Correlation of pancreatic duct type to pancreatic-
bile duct diseases and ERCP-related complica-
tions
No statistically significant correlation was de-
Table 1. Frequencies of the Subtypes of Pancreatic Ductal System (n = 582)
N
Type A (%) Type B (%) Type C (%)
A1 A2 A3 A4 A5 A6 B1 B2 B3 B4 B5 C1 C2 C3 C4 D1 D2 D3 D4
Total 582
254
(43.6)
70
(12.0)
15
(2.6)
2
(0.3)
26
(4.5)
124
(21.3)
37
(6.4)
6
(1.0)
10
(1.7)
2
(0.3)
1
(0.2)
12
(2.1)
7
(1.2)
0
(0)
1
(0.2)
12
(2.0)
1
(0.2)
1
(0.2)
1
(0.2)
Male 325
132
(40.6)
34
(10.5)
9
(2.8)
1
(0.3)
16
(4.9)
78
(24.0)
24
(7.4)
6
(1.8)
6
(1.8)
1
(0.3)
1
(0.3)
8
(2.5)
3
(0.9)
0
(0)
1
(0.3)
5
(1.5)
0
(0)
0
(0)
0
(0)
Female 257
122
(47.5)
36
(14.0)
6
(2.3)
1
(0.4)
10
(3.9)
46
(17.9)
13
(5.1)
0
(0)
4
(1.6)
1
(0.4)
0
(0)
4
(1.6)
4
(1.6)
0
(0)
0
(0)
7
(2.8)
1
(0.4)
1
(0.4)
1
(0.4)
Table 2. Frequencies of Anatomical Anomalies of Pan-
creatic Ductal System
Pancreatic ductal system No. of cases (%)
Normal 531 (91.2)
Anomalous 51 (8.8)
Migration anomaly 0 (0.0)
Fusion anomaly 19 (3.3)
Complete pancreas divisum 12 (2.1)
Incomplete pancreas divisum 7 (1.2)
Duplication anomaly 32 (5.5)
Number variation 5 (0.9)
Form variation 27 (4.6)
Ring 18 (3.1)
Spiral 9 (1.5)Seungmin Bang, et al.
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tected between PD type and pancreatic-bile duct
diseases, including choledocholithiasis, cholangio-
carcinoma, acute and chronic pancreatitis, and
pancreatic cancer (Table 3).
However, the relationship between the type of
PD system and post-ERCP complications was dif-
ferent. The assessment of the presence of asymp-
tomatic hyperamylasemia and pancreatitis after
ERCP was possible in 289 of 582 patients. Among
these patients, asymptomatic hyperamylasemia
occurred in 59 cases (20.4%). The analysis of the
post-ERCP hyperamylasemia according to PD
type showed that the rate of post-ERCP hypera-
mylasemia was 19.8% (47/237) in type A, 9.4%
(3/32) in type B, 41.7% (5/12) in type C, and 50%
(4/8) in type D cases (Table 4). The rate of hyper-
amylasemia in types C and D was significantly
higher than in types A and B (p = 0.018). Clinically
overt post-ERCP pancreatitis occurred in 1.7%
(5/289) of the evaluated patients. There were no
significant differences between the four PD types
for other factors related to post-ERCP pancreatitis
or hyperamylasemia, including age, gender, and
difficulty in visualization of pancreaticobiliary
ductal system.
DISCUSSION
Pancreatic ductal system, as well as the closely
related bile duct, shows diverse morphology and
anatomical variation, and various classification
methods have been reported.
13-19 However, with
these methods, a detailed classification based on
the morphology of pancreatic duct is not possible.
In current study, the morphology of pancreatic
duct was evaluated based on the classification
system described by Stolte et al.
10 In this system,
pancreatic ductal systems are classified into four
major types according to the relationship between
Wirsung duct, Santorini duct, and common bile
duct. The types were then further subdivided
based on the morphology of Wirsung duct and
Santorini duct, and thus provided a more precise
classification.
The results of this study are similar to those of
previous reports. The type in which Wirsung duct
forms the main pancreatic duct and opens into the
major papilla turned out to be the most prevalent,
and the frequency of this type was approximately
66-90% in previous studies.
15,16 Santorini duct has
been reported to be present in 50-100% of cases
in previous studies,
7 and in this study the
frequency was 76.7%. Even though the B type
tended to be more prevalent in males and D type
more prevalent in females, there was no signi-
ficant difference in the morphology of pancreatic
ductal system between genders.
The anatomical anomalies of pancreatic duct
were classified based on the developmental
system proposed by Siegel et al.
11 In this study,
migration anomalies such as annular pancreas
and ectopic pancreas were not detected. This is
partially attributable to a low incidence of annular
pancreas, about 3 in 20,000 cases of autopsies,
17
Table 3. Frequencies of Pancreatobiliary Diseases by Pancreatic Duct Type
Type n Acute pancreatitis Chronic pancreatitis Pancreatic cancer Biliary stone Biliary cancer
A 491 19 (3.9) 63 (12.8) 34 (6.9) 203 (41.3) 35 (7.1)
B 56 1 (1.8) 8 (14.3) 2 (3.6) 20 (35.7) 8 (14.3)
C 20 1 (5.0) 4 (20.0) 2 (10.0) 6 (30.3) 3 (15.0)
D 15 0 (0.0) 2 (13.3) 1 (6.7) 6 (40.0) 2 (13.3)
Total 582 21 (3.6) 77 (13.2) 39 (6.7) 235 (40.4) 48 (8.2)
Table 4. Incidence of Post-ERCP Hyperamylasemia by
Pancreatic Duct Type
Type n Hyperamylasemia (%)*
A 237 47 (19.8)
B 32 3 (9.4)
C 12 5 (41.7)
D 8 4 (50)
Total 289 59 (20.4)
*p value = 0.018.Morphologies of the Pancreatic Ductal System
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and to technical difficulty in the detection of
ectopic pancreas with ERCP. Fusion anomalies are
sub-classified into complete pancreas divisum and
incomplete pancreas divisum. Complete pancreas
divisum has been reported as a relatively rare
condition with the frequency of 0.5-11%, and in
our study, the frequency was 2.1%.
16,20 Incomplete
pancreas divisum is less frequent than complete
pancreas divisum, the frequency is approximately
0.13-0.9%, and in our study, it was 1.2%, which is
slightly higher than previous reports.
21,22 Dupli-
cation anomalies are also uncommon, and Uomo
et al.
23 reported the frequency to be approximately
4.6%, which is similar to the 5.5% detected in our
study.
Acute pancreatitis, chronic pancreatitis, and
pancreatic cancer were more prevalent in type C
ductal systems than in other types, however, a
statistically significant correlation was not de-
tected. The type C pancreatic ductal system con-
tains the fusion anomalies such as complete or
incomplete pancreas divisum. Although further
study is warranted, the complete pancreas di-
visum is reported as associated with acute and
recurrent pancreatitis.
23-28 The frequency of com-
plete pancreas divisum in the cases of acute pan-
creatitis is reported as approximately 25-38%.
23,27
In our study, complete pancreas divisum asso-
ciated with acute pancreatitis was more frequent
than the cases diagnosed without concurrent
acute pancreatitis (9.5% vs. 2.0%).
No statistically significant correlation was
found when examining the association between
bile duct diseases and the morphology of the
pancreatic duct. However, this lack of correlation
may not indicate that there is never a correlation
because the classification system adopted in this
study is oriented toward pancreatic ductal mor-
phology rather than the relationship of the pan-
creaticobiliary ductal system.
The frequencies of post-ERCP pancreatitis and
asymptomatic hyperamylasemia were 1.7% and
20.4%, respectively. No significant complications,
including perforation, hemorrhage or severe pan-
creatitis, were seen in this study. Pancreatic duct
type was the only risk factor found in this study
for post-ERCP hyperamylasemia and pancrea-
titis, though this may be associated with selec-
tion bias. This study included cases in which
both pancreatic duct and biliary duct were com-
pletely visualized. With this criterion, some dif-
ficult cases in the ERCP procedure might be ex-
cluded.
The rate of post-ERCP pancreatitis in this study
(1.7%) is comparable to previous studies in which
it was 1.3-11.3%.
29-31 As post-ERCP pancreatitis
was less frequent in types A and B, it is likely
related to whether or not Wirsung duct forms the
main pancreatic duct.
On the contrary, the incidence of post-ERCP
hyperamylasemia in this study was 20.4%, which
is slightly higher than that reported in previous
studies (7.7-16.5%).
32-34 Considering that the inci-
dence of post-ERCP hyperamylasemia in type A
cases was higher than in type B cases, the pres-
ence of Santorini duct may have an influence on
the risk of post-ERCP hyperamylasemia and
pancreatitis. Although asymptomatic hyperamy-
lasemia is usually irrelevant to clinical prognosis,
it has been reported that some cases with hyper-
amylasemia show a temporal pancreatic endocrine
dysfunction, such as glucose intolerance.
35 Thus,
asymptomatic hyperamylasemia may reflect dam-
age to the pancreas by ERCP.
In conclusion, differences in the morphology of
pancreatic ductal system seem to be unrelated to
demographic factors including gender and pan-
creaticobiliary diseases, although complete pan-
creas divisum may be associated with acute pan-
creatitis. However, there are possible relationships
between the morphologic type of the pancreatic
ductal system and post-ERCP hyperamylasemia
and pancreatitis. Whether or not Wirsung duct
forms the main pancreatic duct is an important
factor in determining the development of pan-
creatitis after ERCP. When visualizing pancreatic
ductal system during the ERCP, this relationship
should be taken into consideration.
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